<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>110(10)</volume><submitter>Dalpiaz O</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>The value of a combined index of neutrophil and white cell counts, named derived neutrophil-lymphocyte ratio (dNLR), has recently been proposed as a prognosticator of survival in various cancer types. We investigated the prognostic role of the dNLR in a large European cohort of patients with upper tract urothelial carcinoma (UTUC).&lt;h4>Methods&lt;/h4>Data from 171 non-metastatic UTUC patients, operated between 1990 and 2012 at a single tertiary academic centre, were evaluated retrospectively. Cancer-specific- (CSS) as well as overall survival (OS) were assessed using the Kaplan-Meier method. To evaluate the independent prognostic significance of the dNLR, multivariate proportional Cox-regression models were applied. Additionally, the influence of the dNLR on the predictive a</pubmed_abstract><journal>British journal of cancer</journal><pagination>2531-6</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4021523</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Validation of the pretreatment derived neutrophil-lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinoma.</pubmed_title><pmcid>PMC4021523</pmcid><pubmed_authors>Martin Hernandez JM</pubmed_authors><pubmed_authors>Zigeuner R</pubmed_authors><pubmed_authors>Dalpiaz O</pubmed_authors><pubmed_authors>Stojakovic T</pubmed_authors><pubmed_authors>Pichler M</pubmed_authors><pubmed_authors>Mannweiler S</pubmed_authors><pubmed_authors>Hutterer GC</pubmed_authors><pubmed_authors>Pummer K</pubmed_authors></additional><is_claimable>false</is_claimable><name>Validation of the pretreatment derived neutrophil-lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinoma.</name><description>&lt;h4>Background&lt;/h4>The value of a combined index of neutrophil and white cell counts, named derived neutrophil-lymphocyte ratio (dNLR), has recently been proposed as a prognosticator of survival in various cancer types. We investigated the prognostic role of the dNLR in a large European cohort of patients with upper tract urothelial carcinoma (UTUC).&lt;h4>Methods&lt;/h4>Data from 171 non-metastatic UTUC patients, operated between 1990 and 2012 at a single tertiary academic centre, were evaluated retrospectively. Cancer-specific- (CSS) as well as overall survival (OS) were assessed using the Kaplan-Meier method. To evaluate the independent prognostic significance of the dNLR, multivariate proportional Cox-regression models were applied. Additionally, the influence of the dNLR on the predictive a</description><dates><release>2014-01-01T00:00:00Z</release><publication>2014 May</publication><modification>2025-04-07T13:02:46.994Z</modification><creation>2019-03-27T01:28:15Z</creation></dates><accession>S-EPMC4021523</accession><cross_references><pubmed>24691424</pubmed><doi>10.1038/bjc.2014.180</doi></cross_references></HashMap>